PACS Group (PACS) versus The Competition Financial Analysis

PACS Group (NYSE:PACS) is one of 93 public companies in the “Medical Services” industry, but how does it weigh in compared to its rivals? We will compare PACS Group to similar businesses based on the strength of its earnings, institutional ownership, analyst recommendations, profitability, valuation, dividends and risk.

Profitability

This table compares PACS Group and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PACS Group	N/A	N/A	N/A
PACS Group Competitors	-785.87%	-50.16%	-11.77%

Valuation and Earnings

This table compares PACS Group and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PACS Group	$3.11 billion	$112.87 million	40.94
PACS Group Competitors	$13.14 billion	$239.88 million	35.02

PACS Group’s rivals have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings for PACS Group and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	1	1	3	0	2.40
PACS Group Competitors	590	2431	5032	179	2.58

PACS Group presently has a consensus price target of $26.25, indicating a potential upside of 106.86%. As a group, “Medical Services” companies have a potential upside of 350.45%. Given PACS Group’s rivals stronger consensus rating and higher possible upside, analysts clearly believe PACS Group has less favorable growth aspects than its rivals.

Insider & Institutional Ownership

58.1% of shares of all “Medical Services” companies are held by institutional investors. 13.2% of shares of all “Medical Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

PACS Group has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, PACS Group’s rivals have a beta of 1.49, meaning that their average share price is 49% more volatile than the S&P 500.

Summary

PACS Group rivals beat PACS Group on 9 of the 13 factors compared.

PACS Group Company Profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.